Table 4.
p-value+ | ||||
---|---|---|---|---|
CONV | UTR | UCR | Overall | |
N participants with dry weight reduction | 12 | 17 | 14 | |
SBP-pre: BCM Measurement [mmHg] | 142 ± 27 | 136 ± 21 | 148 ± 21 | 0.28 |
SBP-pre: Start Intervention Phase [mmHg] | 146 ± 19 | 143 ± 26 | 154 ± 27 | 0.45 |
SBP-post: Start Intervention Phase [mmHg] | 133 ± 22 | 132 ± 17 | 144 ± 31 | 0.34 |
SBP-pre: End Intervention Phase [mmHg] | 127 ± 20 | 127 ± 15 | 136 ± 13 | 0.26 |
SBP-post: End Intervention Phase [mmHg] | 112 ± 16 | 117 ± 15 | 129 ± 22 | 0.06 |
Delta SBP-pre: Start-to-End In Phase [mmHg] | −16 ± 23 | −16 ± 17 | −19 ± 27 | 0.43 |
Delta SBP-post: Start-to-End In Ph. [mmHg] | −19 ± 19 | −16 ± 11 | −15 ± 31 | 0.27 |
CONV conventional hemodialysis, UTR ultrafiltration and temperature regulation, UCR ultrafiltration and dialysate conductivity regulation, N number, ECV extracellular volume, SBP systolic blood pressure, DBP diastolic blood pressure, BCM body composition monitor
PP analysis. + P-values between groups determined by two-tailed t-test, and Mann-Whitney U test. Overall p-values determined by analysis of variance and analysis of covariance (for comparison of repeated measures). In one patient from the UTR group only absolute fluid overload values could be measured; relative fluid overload values could not be calculated by the BCM device due to technical issues, resulting in deviation of the FO value from ECV